Alberta's Aurora Cannabis to Ship Pot to Australia
Edmonton, Alberta-headquartered Aurora Cannabis Inc. has received the required Canadian permits to export cannabis to the Pharmacy Australia Centre of Excellence at the University of Queensland for research purposes. The cannabis will be shipped from Canada by Aurora and used for Preveceutical Medical Inc.'s soluble gel drug delivery research program in partnership with UniQuest Pty Inc. The researcher partnership is developing a new soluble-gel, nose-to-brain delivery system with cannabinoids to provide relief from a range of symptoms, including pain, inflammation, seizures, and neurological disorders. In consideration of the shipment, Aurora has received certain rights, including the option to either license, on a non-exclusive basis, the technology for Canada and Australia, or to opt for a royalty arrangement on product sales, as well as to purchase shares in PreveCeutical. Aurora's wholly-owned subsidiary, Aurora Cannabis Enterprises Inc., is a licensed producer of medical cannabis pursuant to Health Canada's Access to Cannabis for Medical Purposes Regulations. The company operates production facilities in Alberta, Quebec, and Denmark. Aurora also owns Berlin-based Pedanios, the leading wholesale importer, exporter, and distributor of medical cannabis in the European Union.